乐普医疗拟以10.88亿元向心泰医疗转让上海民为生物54.2384%股权

财中社
Aug 21

8月21日,乐普医疗(300003)发布公告,公司将持有的上海民为生物技术有限公司54.2384%的股权转让给控股子公司心泰医疗(02291),交易价款为10.88亿元。  此次股权转让后,公司不再直接持有上海民为生物的股权,心泰医疗将成为其控股股东。交易款项中60%将在交割前提条件满足后支付,剩余40%将在工商变更完成之日起18个月内支付完毕。  2026年中期,乐普医疗实现收入32.14亿元,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10